Company Filing History:
Years Active: 2024
Title: Seong Hyun Ho: Innovator in Gene Therapy Technologies
Introduction
Seong Hyun Ho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of gene therapy and DNA vaccine development. His innovative work has led to advancements in eukaryotic cell expression vectors, which are crucial for effective gene therapies.
Latest Patents
Seong Hyun Ho holds a patent for the "Development of optimized recombinant expression construct." This patent focuses on creating a eukaryotic cell expression vector that meets optimized conditions for gene therapies and DNA vaccines. By replacing the full HCMV regulatory and transcribed region, including the immediate early (IE) gene intron A of the HCMV Towne strain, he was able to enhance gene expression efficiency. The resulting eukaryotic cell expression vector can increase the expression of various genes by approximately 50-150% compared to the HCMV Towne strain. This advancement has led to the development of pHP3, a vector that exhibits high expression in eukaryotic cells, making it a valuable tool for gene therapies and DNA vaccines. Seong Hyun Ho has 1 patent to his name.
Career Highlights
Seong Hyun Ho is currently associated with G&P Bioscience Co., Ltd., where he continues to work on innovative solutions in the biotechnology sector. His expertise in gene therapy technologies has positioned him as a key player in the field.
Collaborations
Seong Hyun Ho collaborates with Su Jin Park, contributing to the advancement of their research and development efforts in gene therapy.
Conclusion
Seong Hyun Ho's contributions to gene therapy and DNA vaccine development highlight his innovative spirit and dedication to advancing biotechnology. His work continues to pave the way for future breakthroughs in the field.